clopidogrel and thalidomide

clopidogrel has been researched along with thalidomide in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	4 (80.00)	24.3611
2020's	1 (20.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Barbieri, KP; Capote, TSO; Carlos, IZ; Chegaev, K; Chelucci, RC; Chung, MC; Coelho, F; Costa, FF; Dos Santos, JL; Fernandes, GFDS; Fruttero, R; Guglielmo, S; Kumkhaek, C; Lanaro, C; Lopes Pires, ME; Marcondes, S; Melo, TRF; Rodgers, GP	1
Bennett, CL; Moore, TJ	1
Bennett, CL; Godwin, AC; Hoque, S; Taylor, MA	1

Reviews

2 review(s) available for clopidogrel and thalidomide

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR). Seminars in thrombosis and hemostasis, 2012, Volume: 38, Issue:8 Topics: Adverse Drug Reaction Reporting Systems; Clopidogrel; Hemorrhage; Humans; Thalidomide; Thrombosis; Ticlopidine; United States; United States Food and Drug Administration; Warfarin	2012

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Underreporting of hemorrhagic and thrombotic complications of pharmaceuticals to the U.S. Food and Drug Administration: empirical findings for warfarin, clopidogrel, ticlopidine, and thalidomide from the Southern Network on Adverse Reactions (SONAR).

Seminars in thrombosis and hemostasis, 2012, Volume: 38, Issue:8

Topics: Adverse Drug Reaction Reporting Systems; Clopidogrel; Hemorrhage; Humans; Thalidomide; Thrombosis; Ticlopidine; United States; United States Food and Drug Administration; Warfarin

2012

Other Studies

3 other study(ies) available for clopidogrel and thalidomide

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Discovery of phenylsulfonylfuroxan derivatives as gamma globin inducers by histone acetylation. European journal of medicinal chemistry, 2018, Jun-25, Volume: 154 Topics: Acetic Acid; Acetylation; Anemia, Sickle Cell; Dose-Response Relationship, Drug; Drug Discovery; gamma-Globins; Histones; Humans; K562 Cells; Molecular Structure; Nitric Oxide; Oxadiazoles; Structure-Activity Relationship	2018
Systemic Barriers and Potential Concerns from Reporting Serious Adverse Drug Reactions. Cancer treatment and research, 2022, Volume: 184 Topics: Clopidogrel; Drug-Related Side Effects and Adverse Reactions; Humans; Immunotherapy; Thalidomide; Ticlopidine; United States	2022